ITCI

Q: What is the price of Intra-Cellular Therapies (ITCI) today?

The price of Intra-Cellular Therapies (ITCI) today is $ 0.00, with return of 0% compared to the last year. The price of Intra-Cellular Therapies (ITCI) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Intra-Cellular Therapies (ITCI) and international markets.

Q: When does Intra-Cellular Therapies (ITCI) pay dividends?

Intra-Cellular Therapies (ITCI) did not distribute dividends in the last year.

Q: Is Intra-Cellular Therapies (ITCI) worth it?

Currently, Intra-Cellular Therapies (ITCI) is priced at $ 0.00, with a P/E of -187.17%, representing a deviation of -8,527% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Intra-Cellular Therapies (ITCI) stock?

Investing in stocks of Intra-Cellular Therapies (ITCI) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Intra-Cellular Therapies (ITCI) yield today?

The yield of Intra-Cellular Therapies (ITCI) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Intra-Cellular Therapies (ITCI) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Intra-Cellular Therapies Inc.

Price

$ -

return (12m)

0.00%

p/e

-187.17

p/bv

12.17

DIVIDEND YIELD

0.00%

ITCI price

ITCI

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ITCI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ITCI

review the fundamentals of Intra-Cellular Therapies shares

P/E

-187.17

Sector: -2.04 Industry: 0.41

P/S (PSR)

20.54

Sector: 1.88 Industry: 2.43

P/BV

12.17

Sector: 2.11 Industry: 2.30

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-5.46%

Sector: -25.47% Industry: -24.33%

ROE

-6.50%

Sector: -29.41% Industry: -29.69%

ROIC

-59.61%

Sector: -411.21% Industry: -75.87%

NET MARGIN

-10.97%

Sector: -28.27% Industry: -30.45%

GROSS MARGIN

91.63%

Sector: 44.66% Industry: 50.55%

OPERATING MARGIN

-17.15%

Sector: -23.29% Industry: -26.81%

EV/EBITDA

-120.28

Sector: -0.79 Industry: 0.98

EV/EBIT

-119.76

Sector: -2.18 Industry: -0.36

PRICE-TO-ASSETS

10.23

Sector: 1.13 Industry: 1.22

BVPS

10.83

Sector: 3.60 Industry: 4.74

EPS

-0.70

Sector: -0.89 Industry: -0.81

EQUITY-TO-ASSETS RATIO

0.84

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.16

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

51.81%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-23.45%

Sector: - Industry: -

Fundamentals ITCI

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	38.09	32.96	86.53%	0.71%	$ 786.02 B	31.66%
ISRG	56.27	8.96	15.92%	0.00%	$ 160.69 B	28.38%
TMO	26.55	3.32	12.52%	0.36%	$ 177.98 B	15.05%
SNY	12.52	1.36	10.86%	4.73%	$ 114.19 B	18.68%
NVS	20.29	6.10	30.04%	4.71%	$ 283.76 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.24	2.27	9.38%	3.25%	$ 111.80 B	13.00%
CVS	50.34	1.18	2.35%	3.80%	$ 89.00 B	0.44%
GSK	14.19	5.07	35.71%	3.10%	$ 108.22 B	17.48%
BSX	35.40	0.00	0.00%	0.00%	$ 102.58 B	14.44%
TMDX	17.70	7.12	40.22%	0.00%	$ 3.37 B	31.43%
HCA	15.86	-38.82	-244.82%	0.61%	$ 107.58 B	8.97%
IDXX	42.16	27.82	65.99%	0.00%	$ 44.67 B	24.62%
RMD	21.66	5.09	23.51%	1.06%	$ 32.19 B	27.53%
DHR	35.51	2.44	6.88%	0.71%	$ 128.33 B	14.71%
INMD	9.00	1.24	13.73%	0.00%	$ 844.20 M	25.32%
PHG	24.55	1.98	8.06%	3.31%	$ 25.47 B	5.07%
FMS	11.18	0.75	6.75%	3.57%	$ 12.62 B	5.02%
SYK	38.64	5.59	14.48%	1.04%	$ 125.41 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ITCI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Intra-Cellular Therapies

Intra-Cellular Therapies Inc.

Average Investor10 user rating

4.0 (0 people)

United States

14 years

Founded: 2012

2013

Time since IPO - 13 years

512

Employees

The Company Intra-Cellular Therapies Inc. (United States), is listed on Nasdaq with a market value of $ 13.98 Billions, having an equity of $ 1.15 Billion.

With a total of 512 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 680.50 Millions, which generated a loss in the amount of $ -74.68 Millions.

As for its main indicators, the Company has a P/E ratio of -187.17, a P/BV ratio of 12.17 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ITCI.

Market cap

$ 13.98 Billions

Net worth

$ 1.15 Billion

US$ 1,148,460,000.00

Assets

$ 1.37 Billion

US$ 1,366,910,000.00

Total Shares Outstanding

106.00 Millions

106,000,000

Average Daily Trading Volume

$ 2.26 Millions

US$ 2,259,894.86

Sector

Health

Industry

Pharmaceutical Products

ITCI

ITCI revenue and profits

Financial Results ITCI

DRAG THE FRAME TO SEE MORE DATA

ITCI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.49 20,99% (12M)

P/E

50.34

3.80%

ROE

2.35%

P/BV

1.18

CI - Cigna

$ 270.02 --14,47% (12M)

P/E

10.14

2.32%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.11 --43,31% (12M)

P/E

-2.36

0.00%

ROE

-33.28%

P/BV

0.79

HUM - Humana

$ 177.83 --28,58% (12M)

P/E

17.08

2.09%

ROE

6.70%

P/BV

1.14

HCA - HCA Healthcare

$ 471.84 43,24% (12M)

P/E

15.86

0.61%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 935.58 30,21% (12M)

P/E

38.09

0.71%

ROE

86.53%

P/BV

32.96

NVS - Novartis

$ 154.03 53,71% (12M)

P/E

20.29

4.71%

ROE

30.04%

P/BV

6.10